Comments on: Buying a Clinically Approved Blood Pressure Monitor http://www.blood-pressure-monitoring.org/blog/buying-a-clinically-approved-blood-pressure-monitor/#utm_source=rss&utm_medium=rss&utm_campaign=buying-a-clinically-approved-blood-pressure-monitor Take Control Of Your Blood Pressure Improve Your Health Fri, 06 Aug 2010 14:00:04 +0000 hourly 1 http://wordpress.org/?v=3.0 By: Brian Packard http://www.blood-pressure-monitoring.org/blog/buying-a-clinically-approved-blood-pressure-monitor/comment-page-1/#comment-35 Brian Packard Mon, 16 Feb 2009 20:40:49 +0000 http://www.blood-pressure-monitoring.org/blog/buying-a-clinically-approved-blood-pressure-monitor/#comment-35 Regarding RESPeRATE to Lower Blood Pressure, this therapeutic device has been proven safe and effective at reducing blood pressure in 10 peer-reviewed clinical studies with over 500 patients. The studies were published in prominent journals such as the UK's Journal of Human Hypertension, the American Journal of Hypertension and the American Heart Association Hypertension Primer. RESPeRATE users with uncontrolled blood pressure experienced a significant decrease in office blood pressure by up to 36 points systolic and 20 points diastolic (top 10% reductions) with average reductions of 14/8 mmHg. RESPeRATE is the only non-drug OTC adjunctive therapy clinically proven to reduce hypertension. It is FDA cleared and CE marked. Unlike blood pressure monitors, RESPeRATE is the only device of its kind. The BHS does not have a protocol (similar to its revised 1993 bpm protocol) or criteria for review of devices such as RESPeRATE. Regarding RESPeRATE to Lower Blood Pressure, this therapeutic device has been proven safe and effective at reducing blood pressure in 10 peer-reviewed clinical studies with over 500 patients. The studies were published in prominent journals such as the UK’s Journal of Human Hypertension, the American Journal of Hypertension and the American Heart Association Hypertension Primer.

RESPeRATE users with uncontrolled blood pressure experienced a significant decrease in office blood pressure by up to 36 points systolic and 20 points diastolic (top 10% reductions) with average reductions of 14/8 mmHg.

RESPeRATE is the only non-drug OTC adjunctive therapy clinically proven to reduce hypertension. It is FDA cleared and CE marked.

Unlike blood pressure monitors, RESPeRATE is the only device of its kind. The BHS does not have a protocol (similar to its revised 1993 bpm protocol) or criteria for review of devices such as RESPeRATE.

]]>